Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $170
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has reiterated its Buy rating on Tenet Healthcare (NYSE:THC) and raised the price target from $155 to $170.
July 25, 2024 | 2:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has reiterated its Buy rating on Tenet Healthcare and raised the price target from $155 to $170.
The reiteration of a Buy rating and an increased price target from a reputable analyst can positively influence investor sentiment and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100